Evidence map›Paper›PMID 30938429›Full record

ArticleBrain : a journal of neurology2019

Variant Creutzfeldt-Jakob disease strain is identical in individuals of two PRNP codon 129 genotypes.

Abigail B Diack, Aileen Boyle, Christopher Plinston, Emma Hunt, Matthew T Bishop, Robert G Will, Jean C Manson

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Brain : a journal of neurology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Variant CJD: Reflections a Quarter of a Century on.Pathogens (Basel, Switzerland) · 2021
    Review
  5. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Abigail B Diack1 The Roslin Institute and R(D)SVS, University of Edinburgh, Easter Bush, UK.
Aileen Boyle1 The Roslin Institute and R(D)SVS, University of Edinburgh, Easter Bush, UK.
Christopher Plinston1 The Roslin Institute and R(D)SVS, University of Edinburgh, Easter Bush, UK.
Emma Hunt1 The Roslin Institute and R(D)SVS, University of Edinburgh, Easter Bush, UK.
Matthew T Bishop1 The Roslin Institute and R(D)SVS, University of Edinburgh, Easter Bush, UK.
Robert G Will1 The Roslin Institute and R(D)SVS, University of Edinburgh, Easter Bush, UK.
Jean C Manson1 The Roslin Institute and R(D)SVS, University of Edinburgh, Easter Bush, UK.
Roslin Institute · GBUniversity of Edinburgh · GB

Funding

Biotechnology and Biological Sciences Research Council BBS/E/D/20002173Biotechnology and Biological Sciences Research Council BBS/E/D/20251967Biotechnology and Biological Sciences Research Council BBS/E/D/20251968Department of Health
6 · The paper itself

Abstract

In 2004, a subclinical case of variant Creutzfeldt-Jakob disease in a PRNP 129 methionine/valine heterozygous individual infected via blood transfusion was reported, and we established that the spleen from this individual was infectious. Since host genetics is an important factor in strain modification, the identification of variant Creutzfeldt-Jakob disease infection in a PRNP 129 methionine/valine heterozygous individual has raised the possibility that the properties of the variant Creutzfeldt-Jakob disease agent could change after transmission to this different genetic background and concerns that this could lead to a more virulent strain of variant Creutzfeldt-Jakob disease. The variant Creutzfeldt-Jakob disease strain has to date been characterized only in methionine homozygous individuals, therefore to establish whether the strain characteristics of variant Creutzfeldt-Jakob disease had been modified by the host genotype, spleen material with prion protein deposition from a PRNP 129 methionine/valine individual was inoculated into a panel of wild-type mice. Three passages in mice were undertaken to allow stabilization of the strain characteristics following its passage into mice. In each passage, a combination of clinical signs, neuropathology (transmissible spongiform encephalopathy vacuolation and prion protein deposition) were analysed and biochemical analysis carried out. While some differences were observed at primary and first subpassage, following the second subpassage, strain characteristics in the methionine/valine individual were totally consistent with those of variant Creutzfeldt-Jakob disease transmitted to 129 methionine/methionine individuals thus demonstrated no alteration in strain properties were imposed by passage through the different host genotype. Thus we have demonstrated variant Creutzfeldt-Jakob disease strain properties are not affected by transmission through an individual with the PRNP methionine/valine codon 129 genotype and thus no alteration in virulence should be associated with the different host genotype.

Indexed as

GenotypeAgedAged, 80 and overAnimalsBrainCodonCreutzfeldt-Jakob SyndromeFemaleGenetic VariationHumansMaleMiceMice, Inbred C57BLMice, TransgenicPrion ProteinsYoung AdultCodonPrion ProteinsPRNP protein, humanprionPRNPtransmissible spongiform encephalopathyvariant Creutzfeldt-Jakob disease

Identifiers

PMID30938429
PMCPMC6487331
OpenAlexW2930213243

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.